Evidence map›Paper›PMID 27440139›Full record

Observational studyBMC pregnancy and childbirth2016

Hair cortisol as a hypothalamic-pituitary-adrenal axis biomarker in pregnant women with asthma: a retrospective observational study.

Laura Smy, Kaitlyn Shaw, Ursula Amstutz, Anne Smith, Howard Berger, Bruce Carleton, Gideon Koren

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC pregnancy and childbirth, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Laura SmyDivision of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, ON, Canada.
Kaitlyn ShawChild & Family Research Institute, Vancouver, BC, Canada.
Ursula AmstutzChild & Family Research Institute, Vancouver, BC, Canada.
Anne SmithChild & Family Research Institute, Vancouver, BC, Canada.
Howard BergerDepartment of Obstetrics & Gynecology, St. Michael's Hospital, Toronto, ON, Canada.
Bruce CarletonChild & Family Research Institute, Vancouver, BC, Canada. bcarleton@popi.ubc.ca.
Gideon KorenDivision of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, ON, Canada.
Child and Family Research Institute · CAHospital for Sick Children · CASt. Michael's Hospital · CAUniversity of Toronto · CA

Funding

CIHR
6 · The paper itself

Abstract

backgroundCortisol is a hormone involved in many physiological functions including fetal maturation and epigenetic programming during pregnancy. This study aimed to use hair cortisol as a biomarker of chronic inhaled corticosteroid (ICS) exposure and assess the potential effects of asthma on the hypothalamic-pituitary-adrenal (HPA) axis in pregnant women. We hypothesized that pregnant women with asthma treated with ICS would exhibit lower hair cortisol concentrations, indicative of adrenal suppression, compared to women with asthma not using ICS and women who do not have asthma.

methodsWe performed an observational retrospective cohort study. Hair samples were analyzed from pregnant women with asthma, with (n = 56) and without (n = 31) ICS treatment, and pregnant women without asthma (n = 31). Hair samples were segmented based on the growth rate of 1 cm/month and analyzed by enzyme immunoassay to provide cortisol concentrations corresponding to preconception, trimesters 1-3, and postpartum. Hair cortisol concentrations were compared within and among the groups using non-parametric statistical tests.

resultsHair cortisol concentrations increased across trimesters for all three groups, but this increase was dampened in women with asthma (P = 0.03 for Controls vs. ICS Treated and Controls vs. No ICS). ICS Treated women taking more than five doses per week had hair cortisol concentrations 47 % lower in third trimester than Controls. Linear regression of the third trimester hair cortisol results identified asthma as a significant factor when comparing consistent ICS use or asthma as the predictor (F(1, 25) = 9.7, P = 0.005, R(2) adj = 0.257).

conclusionsHair cortisol successfully showed the expected change in cortisol over the course of pregnancy and may be a useful biomarker of HPA axis function in pregnant women with asthma. The potential impact of decreased maternal cortisol in women with asthma on perinatal outcomes remains to be determined.

Indexed as

Administration, InhalationAdrenal Cortex HormonesAdrenal GlandsAdultAsthmaBiomarkersFemaleHairHumansHydrocortisoneHypothalamo-Hypophyseal SystemPituitary-Adrenal SystemPostpartum PeriodPregnancyPregnancy ComplicationsPregnancy Trimester, ThirdAdrenal Cortex HormonesBiomarkersHydrocortisoneAdrenal suppressionAsthmaBiomarkerHair cortisolHPA axisPregnancy

Identifiers

PMID27440139
PMCPMC4955128
OpenAlexW2497981355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.